Medgen Drugs And Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.16 M
- Revenue Growth -14.18%
- Profit Growth 2.60%
- Ebitda 3.83%
- Net Worth 56.43%
- Total Assets -40.94%
About Medgen Drugs And Laboratories
Medgen Drugs And Laboratories Private Limited (MDALPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 January 2019 (Six years 10 days old ). Its registered office is in Cuttack, Orissa, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.16 M.
Khagesh Bal and Diptimayee Bal serve as directors at the Company.
Company Details
-
Location
Cuttack, Orissa, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290OR2019PTC030398
-
Company No.
030398
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Jan 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
What products or services does Medgen Drugs And Laboratories Private Limited offer?
Medgen Drugs And Laboratories Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Digestive System Drugs & Medicines, Antacid Drugs, Cardiovascular Drugs & Medication, Diabetes Medicine, Anti Ulcer Drugs, Sexual Wellness Products, Fertility Enhancer.
Who are the key members and board of directors at Medgen Drugs And Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Khagesh Bal
|
Managing Director | 30-Jan-2019 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Diptimayee Bal
|
Director | 30-Jan-2019 | Current |
Financial Performance of Medgen Drugs And Laboratories.
Medgen Drugs And Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.18% decrease. The company also saw a slight improvement in profitability, with a 2.6% increase in profit. The company's net worth Soared by an impressive increase of 56.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medgen Drugs And Laboratories?
In 2023, Medgen Drugs And Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Metsun Laboratories Private LimitedKhagesh Bal and Diptimayee Bal are mutual person
Charges (Loans)
₹9.16 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.92 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2023 | Hdfc Bank Limited | ₹7.00 M | Open |
| 03 Mar 2023 | Hdfc Bank Limited | ₹2.16 M | Open |
How Many Employees Work at Medgen Drugs And Laboratories?
Medgen Drugs And Laboratories has a workforce of 27 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medgen Drugs And Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medgen Drugs And Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.